MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biomaterials (Orthopedic: Synthetic Bone, Cartilage & Skin Substitutes)
Sanara MedTech Inc. (NASDAQ:SMTI)
Organization & Developments: Sanara MedTech
Parents
Sanara MedTech Inc. (NASDAQ:SMTI)
Children
*The company derives the bulk of revenue volume from sales of the CellerateRX surgical powder.
*This is a hydrolyzed collagen that is indicated for surgical and non-surgical wound care, burns included.
2022: Sanara MedTech: A High Growth Micro Cap Disrupting The Wound And Skin Care Space_ seekingalpha.com
2022: Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure_seekingalpha.com
2022: Sanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm Buy_ seekingalpha.com
2023: Sizing Up Sanara MedTech_ seekingalpha.com
2024: Sanara MedTech Inc. 2023 Q4 - Results - Earnings Call Presentation
2025: Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)
2025: Sanara MedTech outlines 26% revenue growth and targets expansion to over 1,450 facilities by year-end 2025 while launching THP pilot
2025: Sanara MedTech Updates Investor Presentation Online_www.tipranks.com
2025: Sanara MedTech: A Promising Growth Story At An Attractive Valuation
2025: Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb_seekingalpha.com
Jumps
Finance & Acquisitions: Sanara MedTech
Key People: Sanara MedTech